Rankings
▼
Calendar
▼
TYRA Q1 2020 Earnings Report — Tyra Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
Tyra Biosciences, Inc.
TYRA
Q1 2020 Earnings
Reported March 30, 2020
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q1 2020
Q4 2019
Q1 2019
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$1M
—
—
—
—
EPS (Diluted)
$-1.07
—
—
—
—
Free Cash Flow
-$2M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$4.0K
GROSS PROFIT
-$4.0K
R&D Expenses
$993.0K
Selling & Marketing
$0
General & Administrative
$463.0K
SG&A Expenses
$463.0K
Other Expenses
$0
Operating Expenses
$1M
Cost & Expenses
$1M
OPERATING INCOME
-$1M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
-$18.0K
INCOME BEFORE TAX
-$1M
Income Tax Expense
$0
NET INCOME
-$1M
D&A
$4.0K
EBIT
-$1M
EBITDA
-$1M
EPS
-$1
EPS Diluted
-$1
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$1M
Depreciation & Amortization
$4.0K
Stock-Based Compensation
$108.0K
Deferred Income Tax
$0
Other Non-Cash Items
-$221.0K
Change in Working Capital
$97.0K
OPERATING CASH FLOW
-$1M
Capital Expenditure
-$56.0K
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$0
NET CASH FROM INVESTING
-$56.0K
Net Debt Issuance
-$4.0K
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$23M
NET CASH FROM FINANCING
$23M
FREE CASH FLOW
-$2M
Net Change in Cash
$22M
marketcaparena.com
← FY 2020
TYRA Overview
Q2 2020 →
